142 related articles for article (PubMed ID: 24840789)
21. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
[No Abstract] [Full Text] [Related]
22. The relationship between liver function and portal pressure: what comes first, the chicken or the egg?
Triantos C; Samonakis D; Thalheimer U; Patch D; Burroughs A
J Hepatol; 2005 Jan; 42(1):146-7; author reply 147-8. PubMed ID: 15629521
[No Abstract] [Full Text] [Related]
23. Beta-blockers.
Bursey RF
Can J Gastroenterol; 1998; 12(8):542-3. PubMed ID: 9926263
[No Abstract] [Full Text] [Related]
24. [Hemodynamic changes and its significance after liver transplantation for cirrhosis and portal hypertension].
Zhang TL
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1689-92. PubMed ID: 19094724
[No Abstract] [Full Text] [Related]
25. Gut microbiota and probiotics in chronic liver diseases.
Cesaro C; Tiso A; Del Prete A; Cariello R; Tuccillo C; Cotticelli G; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2011 Jun; 43(6):431-8. PubMed ID: 21163715
[TBL] [Abstract][Full Text] [Related]
26. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis.
Dumont AE; Witte CL; Witte MH
Lymphology; 1975 Dec; 8(4):111-3. PubMed ID: 1214504
[TBL] [Abstract][Full Text] [Related]
27. [Portal hypertensive gastropathy in cirrhosis].
Møller S; Becker PU; Henriksen JH
Ugeskr Laeger; 1993 May; 155(19):1480-1. PubMed ID: 8316979
[No Abstract] [Full Text] [Related]
28. Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
García-Pagán JC; Gracia-Sancho J; Bosch J
J Hepatol; 2012 Aug; 57(2):458-61. PubMed ID: 22504334
[No Abstract] [Full Text] [Related]
29. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
Orrego Matte H
Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
[No Abstract] [Full Text] [Related]
30. [Clinico-pathogenetic and pharmacotherapeutic aspects of portal hypertension in liver cirrhosis].
Ryss ES; Fishzon-Ryss IuI
Ter Arkh; 1989; 61(8):65-8. PubMed ID: 2686074
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal tract in liver disease: which organ is sick?
Norman K; Pirlich M
Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):613-9. PubMed ID: 18685458
[TBL] [Abstract][Full Text] [Related]
32. Carvedilol for portal hypertension in patients with cirrhosis.
Bosch J
Hepatology; 2010 Jun; 51(6):2214-8. PubMed ID: 20513005
[No Abstract] [Full Text] [Related]
33. [Spironolactone in the treatment of portal hypertension in liver cirrhosis. A new therapeutic principle?].
Klein CP
Dtsch Med Wochenschr; 1985 Nov; 110(46):1774-6. PubMed ID: 4054003
[TBL] [Abstract][Full Text] [Related]
34. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
35. Use of a nonselective beta-blocker, nadolol, in the treatment of portal hypertension in cirrhotics.
Gatta A; Sacerdoti D; Merkel C; Rossoni R; Finucci G; Bolognesi M; Zuin R
Int J Clin Pharmacol Res; 1985; 5(6):413-8. PubMed ID: 4093219
[TBL] [Abstract][Full Text] [Related]
36. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension].
Garbuzenko DV
Klin Med (Mosk); 2007; 85(8):15-9. PubMed ID: 17926483
[TBL] [Abstract][Full Text] [Related]
37. [Effect of cimetidine on wedged hepatic venous pressure in cirrhotic patients].
Leng XS
Zhonghua Wai Ke Za Zhi; 1991 Aug; 29(8):500-2, 525-6. PubMed ID: 1813246
[TBL] [Abstract][Full Text] [Related]
38. Transient elastography for diagnosis of portal hypertension in liver cirrhosis: is there still a role for hepatic venous pressure gradient measurement?
Lim JK; Groszmann RJ
Hepatology; 2007 May; 45(5):1087-90. PubMed ID: 17464984
[No Abstract] [Full Text] [Related]
39. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
Schneider AW; Kalk JF; Klein CP
Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of extrahepatic vasodilation in portal hypertension.
Hennenberg M; Trebicka J; Sauerbruch T; Heller J
Gut; 2008 Sep; 57(9):1300-14. PubMed ID: 18445644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
